When a medicine problem needs help
For a current severe reaction, use the emergency route below before reading the rest of this page. A public reporting form is a different task from getting care.
Which help route fits the problem?
When is emergency help needed?
A severe allergy can cause anaphylaxis, a reaction that threatens life. MedlinePlus says its signs often come on in seconds or minutes. The signs in the source recorded September 17, 2026 include breathing or swallowing problems. The tongue or face may swell.
For severe symptoms of anaphylaxis, MedlinePlus directs people to call 911 or go to an emergency department. This is its emergency advice, not a test for diagnosing yourself.
Sepsis is an extreme body response to infection. CDC treats this response as an emergency because it can be life-threatening. Its account recorded September 17, 2026 lists signs such as confusion, extreme discomfort, and shortness of breath.
These signs help make the need for urgent care clear. They cannot tell what caused a person’s symptom. Do not use a source drawer or a report form to resolve an emergency.
What if the amount taken may be wrong?
MedlinePlus identifies the poison control helpline as a route for overdose help. The resource recorded September 17, 2026 is linked below; no dose calculations or conversions are provided here.
FDA has received reports of compounded semaglutide dosing errors, including events requiring hospital care. The account checked November 3, 2026 describes mistakes both in measuring and in professional calculations.
Keep the product details and the written instructions available for the professional helping with the problem. If the instructions are unclear, request an answer from the prescriber or pharmacist rather than working out a conversion from online examples.
What if the delivery or label seems wrong?
FDA’s account checked November 3, 2026 describes fraudulent compounded semaglutide and tirzepatide labels, including pharmacy names that do not exist or do not belong to the actual maker. A printed name alone is not proof of the source.
For injectable GLP-1 medicines that arrive warm or without enough refrigeration, FDA’s advice recorded September 17, 2026 is not to use the product. Storage requirements otherwise depend on the exact medicine; there is no universal cold-storage rule for peptides.
Georgia’s delivery rules reviewed September 28, 2026 call for a pharmacy process to report and address compromised shipments. Use the named pharmacy’s process and keep the delivery details for that discussion.
How can a problem be reported?
MedWatch is FDA’s medical-product reporting program, open to patients and consumers as well as professionals. The reporting route was documented September 17, 2026.
Adverse event is a reporting term. It refers to an unwanted experience linked with a medical product’s use. FDA warns that a report alone cannot prove cause. The reports also cannot tell how often an event happens.
For a nonurgent conversation, ask the treating clinician which details are needed and how follow-up will happen. Keep the exact medicine name, timing, and pharmacy details together. Reporting can add to the public record, while the care discussion addresses what is happening to you.